Tuesday, October 9, 2007

NOR-98 SCRAPIE UPDATE AUGUST 31, 2007 RISES TO 5 DOCUMENTED CASES

Thursday, November 01, 2007 6:38 AM UPDATE


ATYPICAL NOR-98 SCRAPIE LOCATION UPDATE ON 5 DOCUMENTED CASES THIS YEAR ;


The flocks of origin are WY, CO, CA, IN, and MN.


personal communication USDA et al. ...TSS


USA NOR-98 SCRAPIE UPDATE AUGUST 31, 2007 RISES TO 5 DOCUMENTED CASES


http://nor-98.blogspot.com/


Government Accountability Project

https://www.blogger.com/comment.g?blogID=3995372399492420922&postID=295754279213239559


TSS



Subject: NOR-98 SCRAPIE UPDATE AUGUST 31, 2007 (RISES TO 5 DOCUMENTED CASES IN USA)


Date: October 9, 2007 at 7:15 am PST


Greetings, seems the NOR-98 atypical scrapie cases are the rise in the USA. ...tss


INFECTED AND SOURCE FLOCKS AS of August 31, 2007, there were 33 scrapie infected and source flocks with open statuses (Figure 3). Five new source flocks and one new infected flock were reported n August (Figure 4) with a total of 64 reported for FY 2007(Figure 5).


snip...


IN FY 2007 TWO FIELD CASES, ONE VALIDATION CASE, AND TWO RSSS CASES WERE CONSISTENT WITH NOR-98 SCRAPIE. ...


(BRINGS A TOTAL OF 5 NOR-98 CASES DOCUMENTED IN 2007 IN USA. ...TSS)


http://www.aphis.usda.gov/animal_health/animal_diseases/scrapie/downloads/monthly_scrapie_rpt.pps


please note sporadic cjd cases on the rise with 'unknown type' increasing drastically. ...tss


NOW, why in the world is no one much speaking about the lates 3 cases of theNOR-98 case in the USA, and what are the potential ramifications thereof;



Subject: Aspects of the Cerebellar Neuropathology in Nor98


Date: September26, 2007 at 4:06 pm PST


P03.141


Aspects of the Cerebellar Neuropathology in Nor98


Gavier-Widén, D1; Benestad, SL2; Ottander, L1; Westergren, E1 1NationalVeterinary Insitute, Sweden; 2National Veterinary Institute,



Norway Nor98 is a prion disease of old sheep and goats. This atypical form of scrapie was first described in Norway in 1998. Several features of Nor98 were shown to be different from classical scrapie including the distribution of disease associated prion protein (PrPd) accumulation in the brain. The cerebellum is generally the most affected brain area in Nor98. The studyhere presented aimed at adding information on the neuropathology in the cerebellum of Nor98 naturally affected sheep of various genotypes in Swedenand Norway. A panel of histochemical and immunohistochemical (IHC) stainings such as IHC for PrPd, synaptophysin, glial fibrillary acidic protein, amyloid, and cell markers for phagocytic cells were conducted. The type of histological lesions and tissue reactions were evaluated. The types of PrPd deposition were characterized. The cerebellar cortex was regularly affected, even though there was a variation in the severity of the lesions from case to case. Neuropil vacuolation was more marked in the molecular layer, but affected also the granular cell layer. There was a loss of granule cells. Punctate deposition of PrPd was characteristic. It was morphologically and in distribution identical with that of synaptophysin, suggesting that PrPd accumulates in the synaptic structures. PrPd was also observed in thegranule cell layer and in the white matter.


*** The pathology features of Nor98 in the cerebellum of the affected sheep showed similarities with those of sporadic Creutzfeldt-Jakob disease in humans.



http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf



what does the Nobel Prize Winner Stanely Prusiner say about atypical scrapie, lets look at that first ;



Published online before print October 20, 2005Proc. Natl. Acad. Sci. USA, 10.1073/pnas.0502296102Medical Sciences


A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes


( sheep prion transgenic mice )Annick Le Dur *, Vincent Béringue *, Olivier Andréoletti , Fabienne Reine *,Thanh Lan Laï *, Thierry Baron , Bjørn Bratberg ¶, Jean-Luc Vilotte ,Pierre Sarradin **, Sylvie L. Benestad ¶, and Hubert Laude **Virologie Immunologie Moléculaires and Génétique Biochimique etCytogénétique, Institut National de la Recherche Agronomique, 78350Jouy-en-Josas, France; Unité Mixte de Recherche, Institut National de laRecherche Agronomique-Ecole Nationale Vétérinaire de Toulouse, InteractionsHôte Agent Pathogène, 31066 Toulouse, France; Agence Française de SécuritéSanitaire des Aliments, Unité Agents Transmissibles Non Conventionnels,69364 Lyon, France; **Pathologie Infectieuse et Immunologie, InstitutNational de la Recherche Agronomique, 37380 Nouzilly, France; and¶Department of Pathology, National Veterinary Institute, 0033 Oslo, Norway

Edited by Stanley B. Prusiner, University of California, San Francisco, CA,and approved September 12, 2005 (received for review March 21, 2005)


Scrapie in small ruminants belongs to transmissible spongiform encephalopathies (TSEs), or prion diseases, a family of fatal neurodegenerative disorders that affect humans and animals and can transmit within and between species by ingestion or inoculation. Conversion of the host-encoded prion protein (PrP), normal cellular PrP (PrPc), into amisfolded form, abnormal PrP (PrPSc), plays a key role in TSE transmission and pathogenesis. The intensified surveillance of scrapie in the European Union, together with the improvement of PrPSc detection techniques, has led to the discovery of a growing number of so-called atypical scrapie cases. These include clinical Nor98 cases first identified in Norwegian sheep on the basis of unusual pathological and PrPSc molecular features and "cases" that produced discordant responses in the rapid tests currently applied tothe large-scale random screening of slaughtered or fallen animals. Worryingly, a substantial proportion of such cases involved sheep with PrP genotypes known until now to confer natural resistance to conventional scrapie. Here we report that both Nor98 and discordant cases, including three sheep homozygous for the resistant PrPARR allele (A136R154R171), efficiently transmitted the disease to transgenic mice expressing ovine PrP, and that they shared unique biological and biochemical features upon propagation in mice. These observations support the view that a truly infectious TSE agent, unrecognized until recently, infects sheep and goatflocks and
may have important implications in terms of scrapie control andpublic health.


--------------------------------------------------------------------------------


Author contributions: H.L. designed research; A.L.D., V.B., O.A., F.R.,T.L.L., J.-L.V., and H.L. performed research; T.B., B.B., P.S., and S.L.B.contributed new reagents/analytic tools; V.B., O.A., and H.L. analyzed data;and H.L. wrote the paper.A.L.D. and V.B. contributed equally to this work.To whom correspondence should be addressed.Hubert Laude,

E-mail: laude@jouy.inra.fr


www.pnas.org/cgi/doi/10.1073/pnas.0502296102


http://www.pnas.org/cgi/content/abstract/0502296102v1


OF COURSE, the USDA et al once was concerned for human health from typical scrapie, and rightly so, typical scrapie transmits to primates by there NON-FORCED ORAL CONSUMPTION ;


76/10.12/4.6


http://www.bseinquiry.gov.uk/files/yb/1976/10/12004001.pdf


J Infect Dis. 2004 Aug 1;190(3):653-60.
Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates.

Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC.
Kuru and Creutzfeldt-Jakob disease of humans and scrapie disease of sheep and goats were transmitted to squirrel monkeys (Saimiri sciureus) that were exposed to the infectious agents only by their nonforced consumption of known infectious tissues. The asymptomatic incubation period in the one monkey exposed to the virus of kuru was 36 months; that in the two monkeys exposed to the virus of Creutzfeldt-Jakob disease was 23 and 27 months, respectively; and that in the two monkeys exposed to the virus of scrapie was 25 and 32 months, respectively. Careful physical examination of the buccal cavities of all of the monkeys failed to reveal signs or oral lesions. One additional monkey similarly exposed to kuru has remained asymptomatic during the 39 months that it has been under observation.

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=6997404&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus


ALSO, The agent responsible for French iatrogenic growth hormone-linked CJD taken as a control is very different from vCJD but is similar to that found in one case of sporadic CJD and one sheep scrapie isolate.


http://www.pnas.org/cgi/content/full/041490898v1


SO, in my opinion, the _myth_ that typical scrapie does not transmit to humans, is just that, a myth. there have never been transmission studies done on man, and I would bet my last bottom dollar, anyone making the statement, would not eat a handful of scrapie infected brains. you do know about james alford don't you, whether or not it was the sheep brains he was fed in the middle east, or something else, this war hero has cjd, and he is very young. this was a tragic story too. dont hear much of that now either. ...


http://www.blackfive.net/main/2004/10/a_dying_hero_ss.html


http://www.blackfive.net/main/2004/03/ssg_james_alfor.html



PLEASE NOTE IN USA CJD UPDATE AS AT JUNE 2007, please note steady increase in
''TYPE UNKNOWN''. ...TSS


1 Acquired in the United Kingdom; 2 Acquired in Saudi Arabia; 3 Includes 17 inconclusive and 9 pending (1 from 2006, 8from 2007); 4 Includes 17 non-vCJD type unknown (2 from 1996, 2 from 1997, 1 from 2001, 1 from 2003, 4 from 2004, 3 from 2005, 4 from 2006) and 36 type pending (2 from 2005, 8 from 2006, 26 from 2007)


http://www.cjdsurveillance.com/pdf/case-table.pdf


TSS


From: "Terry S. Singeltary Sr."

Sent: Tuesday, August 21, 2007 9:50 AM

Subject: TWO MORE Nor98 atypical Scrapie cases detected in USA bringingtotal to 3 cases to date


Infected and Source Flocks As of June 30, 2007, there were .....


snip...


One field case and one validation case were consistent with Nor-98 scrapie.


http://www.aphis.usda.gov/animal_health/animal_diseases/scrapie/downloads/monthly_scrapie_rpt.pps


IN the February 2007 Scrapie report it only mentions; ''One case was consistent with Nor98 scrapie.''


http://www.aphis.usda.gov/animal_health/animal_diseases/scrapie/


(please note flocks of origin were in WY, CO, AND CA. PERSONAL COMMUNCATIONS USDA, APHIS, VS ET AL. ...TSS)


NOR98 SHOWS MOLECULAR FEATURES REMINISCENT OF GSS


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=14553


An evaluation of scrapie surveillance in the United States


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=3427


FOIA REQUEST FOR ATYPICAL TSE INFORMATION ON VERMONT SHEEP


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=10451


NEW SCIENTIST MAGAZINE 4/02/01


NEW SCIENTIST EDITORIAL PAGE 3MAD SHEEP DISEASE?


IF THERE is one categorical pronouncement you can safely make about prion diseases like BSE or CJD, it is that one should not make categorical pronouncements. "British beef is safe" and "there is no BSE in Germany" come to mind. Now there are two more: "scrapie is safe", and "people don't catch sporadic CJD". Scrapie is the most widespread prion disease, infecting untold numbers of sheep worldwide. Sporadic CJD is theold-fashioned pre-BSE kind that is supposed to happen spontaneously in unlucky people. But a surprise observation in France suggests some sCJD cases--though by no means all--maybe linked to scrapie after all (see p 4). For years, British authorities asserted that BSE was harmless because it was a form of scrapie. In fact, the only evidence scrapie is safe is some broad-brush epidemiology, good as far as it goes but unable to reveal occasional risks for some people from some sheep. Alarm bells should have rung in 1980 when researchers gave monkeys scrapie by feeding them infected brains. But that research, like so much other work on prion diseases, was never followed up. We still have little idea what BSE does in pigs and chickens. The Queniborough vCJD outbreak (see p 5) would be easier to understand if we knew how much brain we must eat to be infected. As for scrapie, it shouldn't take a chance finding to tell us that there may be dangerous sheep out there.


Suspect symptoms


What if you can catch old-fashioned CJD by eating meat from a sheep infected with scrapie?


Exclusive from New Scientist magazine


Four years ago, Terry Singeltary watched his mother die horribly from a degenerative brain disease.................


full text url follows


By Debora MacKenzie


Suspect Symptoms


http://www.newscientist.com/channel/health/bse/mg16922840.300


if url dead, go here for 'SUSPECT SYMPTOMS'


you can access article here also;


http://www.mad-cow.org/UKCJD/CJD_news52.html#29%20Mar%2001%20-%20CJD%20-%20Suspect%20symptoms



http://www.organicconsumers.org/meat/scrapiecjd.cfm


Then follow up with PNAS studies from which new scientist article written from;


Published online before print March 20, 2001


Proc. Natl. Acad. Sci. USA, 10.1073/pnas.041490898


Abstract of this ArticleReprint (PDF) Version of this ArticleSimilar articles found in:


PNAS OnlinePubMedPubMed CitationSearch Medline for articles by:


Lasmézas, C. I. Deslys, J.-P.Alert me when: new articles cite this article Download to Citation Manager Neurobiology


Adaptation of the bovine spongiform encephalopathy agent to primates andcomparison with Creutzfeldt- Jakob disease: Implications for human health


Corinne Ida Lasmézas*, [dagger] , Jean-Guy Fournier*, Virginie Nouvel*,Hermann Boe*, Domíníque Marcé*, François Lamoury*, Nicolas Kopp [Dagger] , Jean-Jacques Hauw§, James Ironside¶, Moira Bruce [] , DominiqueDormont*, and Jean-Philippe Deslys** Commissariat à l'Energie Atomique, Service de Neurovirologie,Direction des Sciences du Vivant/Département de Recherche Medicale,Centre de Recherches du Service de Santé des Armées 60-68, Avenue duGénéral Leclerc, BP 6, 92 265 Fontenay-aux-Roses Cedex, France; [Dagger] Hôpital Neurologique Pierre Wertheimer, 59, Boulevard Pinel, 69003Lyon, France; § Laboratoire de Neuropathologie, Hôpital de laSalpêtrière, 83, Boulevard de l'Hôpital, 75013 Paris, France; ¶Creutzfeldt-Jakob Disease Surveillance Unit, Western General Hospital,Crewe Road, Edinburgh EH4 2XU, United Kingdom; and [] Institute forAnimal Health, Neuropathogenesis Unit, West Mains Road, Edinburgh EH93JF, United KingdomEdited by D. Carleton Gajdusek, Centre National de la RechercheScientifique, Gif-sur-Yvette, France, and approved December 7, 2000(received for review October 16, 2000)


Abstract


There is substantial scientific evidence to support the notion that bovine spongiform encephalopathy (BSE) has contaminated human beings, causing variant Creutzfeldt-Jakob disease (vCJD). This disease has raised concerns about the possibility of an iatrogenic secondary transmission to humans, because the biological properties of the primate-adapted BSE agent are unknown. We show that (i) BSE can be transmitted from primate to primate by intravenous route in 25 months, and (ii) an iatrogenic transmission of vCJD to humans could be readily recognized pathologically, whether it occurs by the central or peripheral route. Strain typing in mice demonstrates that the BSE agent adapts to macaques in the same way as it does to humans and confirms that the BSE agent is responsible for vCJD not only in the United Kingdom but also in France. The agent responsible for French iatrogenic growth hormone-linked CJD taken as a control is very different from vCJD but is similar to that found in one case of sporadic CJD and one sheep scrapie isolate. These data will be key in identifying the origin of human cases of prion disease, including accidental vCJD transmission, and could provide bases for vCJD risk assessment.


Introduction


The recognition of a variant of the human transmissible spongiform encephalopathy (TSE) Creutzfeldt-Jakob Disease (vCJD) in the U.K. in 1996 raised the major concern that it would correspond to human infection with the agent responsible for bovine spongiform encephalopathy (BSE; ref. 1). Transmission of BSE to macaques provided the first experimental evidence as it produced a disease close to vCJD in humans (2). Strain typing in inbred mice (consisting of measuring the incubation period and establishing lesion profiles corresponding to the strain-specific distribution of brain vacuolation) allows reliable identification of TSE strains (3). This method, together with biochemical methods, has revealed a single phenotype for the agents ofBSE and the British cases of vCJD (4-6). Mice expressing only the bovine prion protein (PrP) were highly susceptible to vCJD and BSE, which induced the same disease (7). Thus, it is now well established that BSE has caused vCJD, probably by alimentary contamination. In this respect,the finding of abnormal PrP labeling in the gastrointestinal tract and lymphatic tissues of orally BSE-contaminated lemurs shows that the BSE agent can infect primates by the oral route (8). About 1 million contaminated cattle may have entered the human food chain, and thefuture number of vCJD cases could range from 63 to 136,000 depending on the incubation period of BSE in humans (9). Unlike sporadic CJD (sCJD) and iatrogenic CJD (iCJD) linked to the administration of contaminated growth hormone extracted from human hypophyses, in vCJD, the infectious agent seems to be widely distributed in lymphoid organs, as pathological PrP (PrPres) can be detected in tonsils, lymph nodes, spleen, and appendix even in the preclinical phase of the disease (10, 11). This raises a public health issue with regard to the risk of iatrogenic transmission of vCJD through surgical instruments, grafts, blood transfusion, or parenteral administration of biological products of human origin. However, this risk is difficult to assess, because it largely depends on factors such as the virulence of the BSE agent adapted to primates and the efficiency of secondary transmission to humans by a peripheral route such as the i.v. one. A further issue is whether vCJD accidentally acquired from humans would be recognized. The latter poses the question of a phenotypic variation of the BSE agentafter successive transmissions in humans: does it retain its strain characteristics, and does it induce a pathology similar to that observed in the previous host? A 9-year history of transmission of BSE to primates and mice enables us today to clarify a number of these important points. Although BSE has mainly affected the U.K., two definite cases and one probable case of vCJD have now been reported in France in people who have never resided in the U.K. (12, 13). We strain-typed the first of these cases to establish its origin. Strain typing in C57BL/6 mice of BSE, French, and British vCJD was compared with that of BSE passaged in nonhuman primates, thus allowing us to study the effect of serial passages in primates. Comparisons were also made with French cases of sCJD and iCJD and two strains of scrapie (one of French and one of U.S. origin).


Our findings provide experimental demonstration that the same agent, namely that responsible for the cattle disease BSE, has causedvCJD both in France and in the U.K., in line with biochemical data and with the fact that, until 1996, about 10% of the beef consumed in France was imported from the U.K. We found that the BSE agent in nonhuman primates is similar to that causing vCJD in humans and tends to evolve rapidly toward a primate-adapted variant.


Furthermore, we showed that the strain responsible for iCJD is closely related to that of one patient with sCJD, and, more unexpectedly, that these agents were similar to the French scrapie strain studied (but different from theU.S. scrapie strain). This finding requires a cautious interpretation for several reasons, not least because of the inevitably limited number of TSE strains that can be studied by such a cumbersome method as straintyping. Nonetheless, it also prompts reconsideration of the possibility that, in some instances, sheep and human TSEs can share a common origin.


snip...


http://www.pnas.org/cgi/content/full/041490898v1


12/10/76 AGRICULTURAL RESEARCH COUNCIL REPORT OF THE ADVISORY COMMITTE ON SCRAPIE


Office Note CHAIRMAN: PROFESSOR PETER WILDY


snip...


A The Present Position with respect to ScrapieA]


The Problem

Scrapie is a natural disease of sheep and goats. It is a slow and inexorably progressive degenerative disorder of the nervous system and it is fatal. It is enzootic in the United Kingdom but not in all countries. The field problem has been reviewed by a MAFF working group(ARC 35/77). It is difficult to assess the incidence in Britain for a variety of reasons but the disease causes serious financial loss; it is estimated that it cost Swaledale breeders alone $l.7 M duringthe five years 1971-1975. A further inestimable loss arises from the closure of certain export markets, in particular those of the United States, to British sheep. It is clear that scrapie in sheep is important commercially and for that reason alone effective measures to control it should be devised as quickly as possible.


Recently the question has again been brought up as to whether scrapie is transmissible to man. This has followed reports that the disease has been transmitted to primates. One particularly lurid speculation (Gajdusek 1977) conjectures that the agents of scrapie, kuru, Creutzfeldt-Jakob disease and transmissible encephalopathy of mink are varieties of a single "virus". The U.S. Department ofAgriculture concluded that it could


"no longer justify or permit scrapie-blood line and scrapie-exposed sheep and goats to be processed for human or animal food at slaughter or rendering plants" (ARC 84/77)"


The problem is emphasised by the finding that some strains of scrapie produce lesions identical to the one which characterise the human dementias "Whether true or not". the hypothesis that these agents might be transmissible to man raises two considerations.


First, the safety of laboratory personnel requires prompt attention.


Second, action such as the "scorched meat" policy of USDA makes the solution of the scrapie problem urgent if the sheep industry is not to suffer grievously.


snip...


76/10.12/4.6


http://www.bseinquiry.gov.uk/files/yb/1976/10/12004001.pdf



Subject: FSIS NOTICE SAMPLE COLLECTION FROM CATTLE UNDER THE BOVINESPONGIFORM ENCEPHALOPATHY (BSE)ONGOING SURVEILLANCE PROGRAMFrom: "Terry S. Singeltary Sr."Reply-To: Sustainable Agriculture Network Discussion GroupDate: Fri, 2 Feb 2007 17:32:58 -0600


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0702&L=sanet-mg&P=720


ABSTRACTS SPORADIC CJD AND H BASE MAD COW ALABAMA AND TEXAS SEPTEMBER 2007 Date: Mon, 24 Sep 2007 21:31:55 -0500


I suggest that you all read the data out about h-BASE and sporadic CJD, GSS,blood, and some of the other abstracts from the PRION2007. ...


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0709&L=sanet-mg&T=0&F=&S=&P=19744


*** PLEASE READ AND UNDERSTAND THE RAMIFICATIONS OF THIS !!!
THE PRICE OF POKER INDEED GOES UP. ...TSS


USA BASE CASE, (ATYPICAL BSE), AND OR TSE (whatever they are calling it today), please note that both the ALABAMA COW, AND THE TEXAS COW, both were''H-TYPE'', personal communication Detwiler et al Wednesday, August 22, 200711:52 PM. ...TSS


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=19779


see full text 143 pages ;


http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf


Terry S. Singeltary Sr.
P.O. Box 42
Bacliff, Texas USA 77518

1 comment:

Terry S. Singeltary Sr. said...

Re: Docket AMS-TM-07-0062 - National Organic Program (NOP) - Amendments to
the National List of Allowed and Prohibited Substances: Interim Final Rule



Government Accountability Project
1612 K Street, NW * Suite 1100
Washington, DC 20006
202-408-0034


August, 14, 2007


Robert Pooler
Agricultural Marketing Specialist
National Organic Program
USDA/AMS/TMP/NOP
1400 Independence Ave. SW
Room 4008-So., Ag Stop 0268
Washington, DC 20250





Re: Docket AMS-TM-07-0062 - National Organic Program (NOP) -
Amendments to the National List of Allowed and Prohibited Substances:
Interim Final Rule




Dear Mr. Pooler,


snip...


http://www.whistleblower.org/doc/2007/AMS-TM-07-0062_FINAL_public_comment_NL_8-14-07.pdf




----- Original Message -----
From: Jacqueline Ostfeld
To: flounder9@verizon.net
Sent: Monday, September 25, 2006 2:10 PM
Subject: Re: MAD COW PROTEIN IN COMMERCE 2006 USA


Dear Mr. Singeltary,



This is a note to let you know I received your email. I have not had a
chance to read it all yet, but I would love to set up a time to speak with
you later in the week about these issues. We actually are taking on a
related case so your insight into testing and surveillance procedures for
animals with TSEs would be really appreciated. Let me know if you are free
to talk later in the week and if so, please send me a number where you can
be reached and some times you are free. Thanks. I look forward to hearing
from you.



Regards,

Jackie Ostfeld



Jacqueline Ostfeld, MA

Food and Drug Safety Associate

Government Accountability Project

1612 K St. NW, Suite 1100

Washington, DC 20006

Phone: (202) 408-0034 Ext. 153

Fax: (202) 408-9855

jacquelineo@whistleblower.org

www.whistleblower.org





NOTICE: This communication may contain privileged or other confidential
information. If you are not the intended recipient, or believe that you have
received this communication in error, please do not print, copy, retransmit,
disseminate, or otherwise use the information. Also, please indicate to the
sender that you have received this communication in error, and delete the
copy you received.



============================


----- Original Message -----
From: Jacqueline Ostfeld
To: Terry S. Singeltary Sr.
Sent: Tuesday, September 26, 2006 8:54 AM
Subject: RE: MAD COW PROTEIN IN COMMERCE 2006 USA


Hi Terry,



Thanks for all the information. I am not sure when I will have a chance to
read through it all, but I definitely will. In the meantime, I would like to
talk to you and just tell you a little bit about what we are doing on the
TSE front, hear a little bit about your work and see if you might have any
suggestions for GAP as we move forward. I spoke with Linda Faillace a few
weeks ago and she recommended that I get in touch with you, too. I can give
you a call at any of the following days/times (all central time zone): today
(Tuesday) at 2pm, Wednesday at 3pm or Thursday at 1pm. Please let me know if
any of these times work for you. Thanks.



Jackie



Jacqueline Ostfeld, MA

Food and Drug Safety Associate

Government Accountability Project

1612 K St. NW, Suite 1100

Washington, DC 20006

Phone: (202) 408-0034 Ext. 153

Fax: (202) 408-9855

jacquelineo@whistleblower.org

www.whistleblower.org





NOTICE: This communication may contain privileged or other confidential
information. If you are not the intended recipient, or believe that you have
received this communication in error, please do not print, copy, retransmit,
disseminate, or otherwise use the information. Also, please indicate to the
sender that you have received this communication in error, and delete the
copy you received.


==========================================


----- Original Message -----
From: Jacqueline Ostfeld
To: Terry S. Singeltary Sr.
Sent: Tuesday, September 26, 2006 3:27 PM
Subject: RE: HUMAN and ANIMAL TSE Classifications i.e. mad cow disease and
the UKBSEnvCJD only theory.doc


Thank you so much Terry. It was great to talk to you. I am impressed with
the level of knowledge you have accumulated over the years. I would like to
talk to you again after I have a chance to read through the information you
sent. It may take a few weeks, as I am also busy with some other projects at
work. Thanks again. I really appreciate your insight. Please feel free to
contact me with any questions. Also, if you come across any potential
whistleblowers looking for legal representation, please feel free to send
them my way.



Regards,

Jackie



PS. Do you have Paul Brown’s email and phone number?



Jacqueline Ostfeld, MA

Food and Drug Safety Associate

Government Accountability Project

1612 K St. NW, Suite 1100

Washington, DC 20006

Phone: (202) 408-0034 Ext. 153

Fax: (202) 408-9855

jacquelineo@whistleblower.org

www.whistleblower.org





NOTICE: This communication may contain privileged or other confidential
information. If you are not the intended recipient, or believe that you have
received this communication in error, please do not print, copy, retransmit,
disseminate, or otherwise use the information. Also, please indicate to the
sender that you have received this communication in error, and delete the
copy you received.



=====================================


----- Original Message -----
From: Jacqueline Ostfeld
To: Terry S. Singeltary Sr.
Sent: Monday, December 04, 2006 1:31 PM
Subject: Atypical Scrapie


Dear Terry,



I spoke with you a month or so ago regarding GAP’s research into scrapie. I
am still doing research on scrapie in the US sheep population and I have a
question that you may be able to answer or perhaps point me in the right
direction. I am wondering if the US has ever found any cases of atypical
scrapie beyond those of the mad sheep in Vermont (which is debatable). Do
you know if the USDA has any procedures or pilot tests in place to try to
identify atypical scrapie or BSE in sheep? Thanks. I look forward to hearing
from you.



Warmest Regards,

Jackie Ostfeld



Jacqueline Ostfeld, MA

Food and Drug Safety Associate

Government Accountability Project

1612 K St. NW, Suite 1100

Washington, DC 20006

Phone: (202) 408-0034 Ext. 153

Fax: (202) 408-9855

jacquelineo@whistleblower.org

www.whistleblower.org





NOTICE: This communication may contain privileged or other confidential
information. If you are not the intended recipient, or believe that you have
received this communication in error, please do not print, copy, retransmit,
disseminate, or otherwise use the information. Also, please indicate to the
sender that you have received this communication in error, and delete the
copy you received.



============================================


----- Original Message -----
From: Jacqueline Ostfeld
To: Terry S. Singeltary Sr.
Sent: Tuesday, December 05, 2006 3:44 PM
Subject: RE: Atypical Scrapie


Thanks! This is all really helpful. Have you seen the following?



Regards,

Jackie Ostfeld



Jacqueline Ostfeld, MA

Food and Drug Safety Associate

Government Accountability Project

1612 K St. NW, Suite 1100

Washington, DC 20006

Phone: (202) 408-0034 Ext. 153

Fax: (202) 408-9855

jacquelineo@whistleblower.org

www.whistleblower.org



UK meat inspectors charge fraud in BSE testing


==============================================snip...end...TSS



----- Original Message -----
From: Jacqueline Ostfeld
To: Terry S. Singeltary Sr.
Sent: Monday, October 22, 2007 9:20 AM
Subject: RE: Atypical Scrapie


Thanks, Terry.



Jackie



---

Jacqueline Ostfeld

Food and Drug Safety Officer

Government Accountability Project

1612 K St. NW, Suite 1100

Washington, DC 20006

Phone: (202) 408-0034, ext. 153

Fax: (202) 408-9855

jacquelineo@whistleblower.org

www.whistleblower.org



NOTICE: This communication may contain privileged or other confidential
information. If you are not the intended recipient, or believe that you have
received this communication in error, please do not print, copy, retransmit,
disseminate, or otherwise use the information. Also, please indicate to the
sender that you have received this communication in error, and delete the
copy you received.


----------------------------------------------------------------------------
----

From: Terry S. Singeltary Sr. [mailto:flounder9@verizon.net]
Sent: Sunday, October 21, 2007 3:53 PM
To: Jacqueline Ostfeld
Subject: Re: Atypical Scrapie



Tuesday, October 9, 2007

NOR-98 SCRAPIE UPDATE AUGUST 31, 2007 RISES TO 5 DOCUMENTED CASES


http://nor-98.blogspot.com/


***PLEASE NOTE IN USA CJD UPDATE AS AT JUNE 2007, please note steady
increase in ''TYPE UNKNOWN''. ...TSS


1 Acquired in the United Kingdom; 2 Acquired in Saudi Arabia; 3 Includes 17
inconclusive and 9 pending (1 from 2006, 8 from 2007); 4 Includes 17
non-vCJD type unknown
(2 from 1996, 2 from 1997, 1 from 2001, 1 from 2003, 4 from 2004, 3 from
2005, 4 from 2006)
and 36 type pending (2 from 2005, 8 from 2006, 26 from 2007)



http://www.cjdsurveillance.com/pdf/case-table.pdf




USA NVCJD BLOOD RECALLS ONLY ;


http://www.google.com/search?hl=en&q=CJD+BLOOD+RECALLS+TSS&btnG=Search


vCJD case study highlights blood transfusion risk


http://vcjdblood.blogspot.com/


CREUTZFELDT JAKOB DISEASE MAD COW BASE, CWD, SCRAPIE UPDATE OCT 2007


http://cjdmadcowbaseoct2007.blogspot.com/


NOR-98 ATYPICAL SCRAPIE USA UPDATE AS AT OCT 2007

Tuesday, October 9, 2007
NOR-98 SCRAPIE UPDATE AUGUST 31, 2007 RISES TO 5 DOCUMENTED CASES


http://nor-98.blogspot.com/



CREUTZFELDT JAKOB DISEASE MAD COW h-BASE UPDATE USA

http://cjdmadcowbaseoct2007.blogspot.com/



ABSTRACTS SPORADIC CJD AND H BASE MAD COW ALABAMA AND TEXAS SEPTEMBER 2007

Date: Mon, 24 Sep 2007 21:31:55 -0500



I suggest that you all read the data out about h-BASE and sporadic CJD, GSS,
blood, and some of the other abstracts from the PRION2007. ...



http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0709&L=sanet-mg&T=0&F=&S=&P=19744





*** PLEASE READ AND UNDERSTAND THE RAMIFICATIONS OF THIS !!! THE PRICE OF
POKER INDEED GOES UP. ...TSS

USA BASE CASE, (ATYPICAL BSE), AND OR TSE (whatever they are calling it
today), please note that both the ALABAMA COW, AND THE TEXAS COW, both were
''H-TYPE'', personal communication Detwiler et al Wednesday, August 22, 2007
11:52 PM. ...TSS



http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=19779



From: "Terry S. Singeltary Sr."
Subject: CWD UPDATE 88 AUGUST 31, 2007


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0709&L=sanet-mg&T=0&P=450


Date: Wed, 29 Aug 2007 21:13:08 -0500
From: "Terry S. Singeltary Sr."
Subject: CWD NEW MEXICO RECORDS IT'S 19 CASE (near Texas border again)


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=26079



Monitoring the Potential Transmission of Chronic Wasting Disease to Humans
Using a Hunter Registry Database in Wyoming (405 lines)
From: Terry S. Singeltary Sr. <[log in to unmask]>
Date: Thu, 30 Aug 2007 21:23:42 -0500


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&F=&S=&P=27654


Subject: Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease
creates a new prion strain

Date: August 25, 2007 at 12:42 pm PST


Subject: Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease
creates a new prion strain
Date: August 25, 2007 at 12:42 pm PST

J Biol Chem. 2007 Aug 20; : 17709374

Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a
new prion strain.

[My paper] Atsushi Kobayashi , Masahiro Asano , Shirou Mohri , Tetsuyuki
Kitamoto

The genotype (methionine or valine) at polymorphic codon 129 of the human
prion protein (PrP) gene and the type (type 1 or type 2) of abnormal isoform
of PrP (PrP(Sc)) are major determinants of the clinicopathological
phenotypes of sporadic Creutzfeldt-Jakob disease (sCJD). Here we found that
transmission of sCJD prions from a patient with valine homozygosity (129V/V)
and type 2 PrP(Sc) (sCJD-VV2 prions) to mice expressing human PrP with
methionine homozygosity (129M/M) generated unusual PrP(Sc) intermediate in
size between type 1 and type 2. The intermediate type PrP(Sc) was seen in
all examined dura mater graft-associated CJD cases with 129M/M and
plaque-type PrP deposits (p-dCJD). p-dCJD prions and sCJD-VV2 prions
exhibited similar transmissibility and neuropathology, and the identical
type of PrP(Sc) when inoculated into PrP-humanized mice with 129M/M or
129V/V. These findings suggest that p-dCJD could be caused by cross-sequence
transmission of sCJD-VV2 prions.


snip...


In this study, the strain-dependent traits of sCJDMM1
prions were inherited through cross-sequence
transmission without any modification. The
humanized mice with 129V/V produced type 1 PrPres
after inoculation with sCJD-MM1 prions. Because
sCJD-VV1 cases are extremely rare (at most 1-2%
of the total number of sCJD cases) and characterized
by early onset (mean age at onset: 39.3 years) (5),

####################################

our results raise the possibility that CJD cases
classified as VV1 may include cases caused by
iatrogenic transmission of sCJD-MM1 prions or
food-borne infection by type 1 prions from animals,
e.g., chronic wasting disease prions in cervid. In fact,
two CJD-VV1 patients who hunted deer or
consumed venison have been reported (40, 41). The
results of the present study emphasize the need for
traceback studies and careful re-examination of the
biochemical properties of sCJD-VV1 prions.

###################################

In conclusion, cross-sequence transmission of
sCJD-VV2 prions generates a new prion strain with
altered conformational properties and disease
phenotypes as p-dCJD prions. Furthermore, the
newly generated prions have unique transmissibility
including the traceback phenomenon. In the future, if
atypical prion strains emerge through cross-sequence
transmission, especially from animals, traceback
studies will enable us to identify the origin of the
prions.

REFERENCES...snip...end

FULL TEXT ;


http://www.jbc.org/cgi/content/abstract/M704597200v1?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=Cross-sequence+transmission+of+sporadic+Creutzfeldt-Jakob+disease+creates+a+new+&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT



http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=21267



Re: Colorado Surveillance Program for Chronic Wasting Disease
Transmission to Humans (TWO SUSPECT CASES)


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0704&L=sanet-mg&T=0&P=1165




Subject: MAD COW BASE H-TYPE AND L-TYPE

Date: August 23, 2007 at 11:30 am PST


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=19779



Quantifying the Species Barrier in Chronic Wasting Disease by a Novel in
vitro Conversion Assay


Li, L1; Coulthart, MB2; Balachandran, A3; Chakrabartty, A4; Cashman, NR1
1University of British Columbia, Brain Research Centre, Canada; 2Public
Health Agency of Canada, National Microbiology Laboratory, Canada; 3Animal
Diseases
Research Institute, Canada Food Inspection Agency, National Reference
Laboratory for Scrapie and CWD, Canada; 4Ontario Cancer Institute and
Department of Medical
Biophysics, University of Toronto, Canada


Background: Chronic wasting disease (CWD) is a transmissible spongiform
encephalopathy that can affect North American cervids (deer, elk, and
moose). Although the risk of CWD crossing the species barrier and causing
human
disease is still unknown, however, definite bovine spongiform encephalopathy
(BSE)
transmission to humans as variant CJD (vCJD), it would seem prudent to limit
the exposure of humans to CWD.


Aim: In view of the fact that BSE can be readily transmitted to non-bovid
species, it is important to establish the species susceptibility range of
CWD.


Methods: In vitro conversion system was performed by incubation of prions
with normal brain homogenates as described before, and protease K (PK)
resistant
PrP was determined by immunoblotting with 6H4 monoclonal prion antibody.


Results: Our results demonstrate that PrPC from cervids (including moose)
can be efficiently converted to a protease-resistant form by incubation with
elk
CWD prions, presumably due to sequence and structural similarities between
these species. Interestingly, hamster shows a high conversion ratio by
PrPCWD.
Moreover, partial denaturation of substrate PrPC can apparently overcome the
structural barriers between more distant species.


Conclusions: Our work correctly predicted the transmission of CWD to a wild
moose. We find a species barrier for prion protein conversion between
cervids and
other species, however, this barrier might be overcome if the PrPC substrate
has been partially denatured in a cellular environment. Such an environment
might also promote CWD transmission to non-cervid species, *** including
humans.
Acid/GdnHCl-treated brain PrPC was a superior substrate for the in vitro
conversion than PrPC treated at physiological pH. This has implications for
the process by which the prion protein is converted in disease.


http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf




P04.61


Survival of PrPSc during Simulated Wastewater Treatment


ProcessesPedersen, J1; Hinckley, G1; McMahon, K2; McKenzie, D3; Aiken,
JM31University of Wisconsin, Soil Science/Civil and Environmental
Engineering,USA; 2University of Wisconsin, Civil and Environmental
Engineering, USA;3University of Wisconsin, Comparative Biosciences,


USA Concern has been expressed that prions could enter wastewater treatment
systems through sewer and/or septic systems (e.g., necropsy laboratories,
rural meat processors, private game dressing) or through leachate from
landfills that have received TSE-contaminated material. Prions are highly
resistant to degradation and many disinfection procedures raising concern
that they could survive conventional wastewater treatment. Here, we report
the results of experiments examiningthe partitioning and survival of PrPSc
during simulated wastewater treatment processes including activated and
mesophilic anaerobic sludge digestion. We establish that PrPSc can be
efficiently extracted from activated and anaerobic digester sludges with
1% sodium dodecyl sulfate, 10% sodium undecyl sulfate, and 1% sodium
N-laurylsarcosinate. Activated sludge digestion does not result in
significant degradation ofPrPSc. The protein partitions strongly to the
activated sludge solids and isexpected to enter biosolids treatment
processes. A large fraction of PrPSc survivedsimulated mesophilic anaerobic
sludge digestion. Our results suggest that if prions were to enter municipal
waste water treatment systems, most of the agent would partition to
activated sludge solids, survive mesophilic anaerobic digestion, and be
present in treated biosolids. Land application of biosolids
containing prions could represent a route for their unintentional
introduction into the environment.Our results argue for excluding inputs of
prions to municipal wastewater treatment facilities that would result in
unacceptable risk of prion disease transmission via contaminated
biosolids.

http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf


P04.01ChronicWasting Disease in a Captive White-Tailed Deer Farm


Keane, D1; Barr, D1;
Bochsler, P1; Hall, M2; Gidlewski, T3; O'Rourke, K4; Spraker, T51University
of Wisconsin, USA; 2US Department of Agriculture, USA; 3US Departmentof
Agriculture, USA; 4USDA ARS-ADRU, Washington |State University,
USA;5Veterinary Diagnostic Laboratory, Colorado State University, USA


A white-tailed deer farm in Portage, Wisconsin, was depopulated in January
2006, after chronic wasting disease (CWD) had been initially discovered on
the property in September 2002. Prior to the depopulation, a total of 22
positive animals had been removed from the property: one in 2002, six in
2003, ten in 2004, four in 2005 and one in 2006. At the time of depopulation
a total of 76 animals remained: 47 females and 29males. Age was assessed by
visual examination of teeth at the time of death and revealed 26 adult, 8
fawn and 42 yearling animals. The following tissues were examined by
immunohistochemistry for PrPCWD using A b99/97.6.1: obex,
tonsil, retropharyngeal, submandibular, parotid, prescapular, axillary,
inguinal, prefemoral andpopliteal lymph nodes, recto-anal mucosal tissue
and eye. Seventy-nine percent ofanimals (sixty) were found to be positive
in at least one tissue; 49 were obex positive, 58 retropharyngeal positive,
56 tonsil positive, 48 recto-anal mucosal associated lymphoid tissue
positive and 4 animals were positive for PrPCWD in the retina.
Priongenotype was determined for all animals.


http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf


Subject: Clinical Observations of BSE Infection in Red Deer
Date: October 4, 2007 at 9:05 am PST

P04.80

Clinical Observations of BSE Infection in Red Deer

Steele, P1; Martin, S2; Jeffrey, M2; González, L2; Sisó, S2; Finlayson, J1;
Hamilton, S1; Eaton, Samatha L1; Reid, Hugh W1; Todd, R1; Pang, Y1;
Chianini, F1;
Dagleish, MP1 1Moredun Research Institute, UK; 2Veterinary Laboratory
Agency, Lasswade, UK


Observation of clinical signs is often the first step in the diagnosis of
TSE diseases in
experimental, farmed and wild animals. Clinical presentation of chronic
wasting
disease (CWD) infected deer varies widely as disease progresses and many
clinical signs observed can be non-specific to TSE infection, however by
terminal
stage the majority of cases involve behavioural changes and loss of body
condition.
We present here the first description of clinical disease in deer
experimentally infected
with BSE. These data are part of the results of an ongoing project to
investigate the
susceptibility of UK red deer (Cervus elaphus elaphus) to BSE infection
either by
alimentary or intra-cerebral infection.
Eighteen European red deer calves (mean 64 days old) were challenged
intragastrically with 25g of BSE-infected bovine brain. Six challenged and 2
control deer
were culled at 6 and 12 month post infection. These animals showed no
clinical signs
and no disease-specific PrP (PrPd) on immunohistochemistry (IHC) examination
of a wide range of tissues collected at post-mortem. Six BSE-dosed and 4
negative
control deer are still alive at time of writing (1384 dpi).
Subsequently, 6 red deer of the same cohort (mean 341 days old) were
challenged with
0.05g of BSE positive bovine brain material and 2 with sterile saline by the
intracerebral route. Currently (1106 dpi), five of the six challenged
animals have
developed clinical signs and terminal disease confirmed by IHC and western
blot
detection of PrPd.
Clinical signs similar to CWD cases have been observed including behavioral
change, wide stance, lowered head, and excessive salivation. All animals had
significant weight loss attributed to inability or unwillingness to feed,
with inhalation
pneumonia occurring in the case of one animal which is commonly observed in
CWD
cases. The first animal to show clinical signs was markedly different to the
four subsequent
cases. This animal had to be culled following several behavioral episodes
causing
physical injury. Our results prove for the first time that UK red deer are
susceptible to
intra-cerebral BSE infection and shows that the clinical presentation of
disease shares
many similarities to that recorded for CWD.


http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf





Terry S. Singeltary Sr.
P.O. Box 42
Bacliff, Texas USA 77518







----- Original Message -----

From: Jacqueline Ostfeld

To: Terry S. Singeltary Sr.

Sent: Monday, December 04, 2006 1:31 PM

Subject: Atypical Scrapie



Dear Terry,



I spoke with you a month or so ago regarding GAP’s research into scrapie. I
am still doing research on scrapie in the US sheep population and I have a
question that you may be able to answer or perhaps point me in the right
direction. I am wondering if the US has ever found any cases of atypical
scrapie beyond those of the mad sheep in Vermont (which is debatable). Do
you know if the USDA has any procedures or pilot tests in place to try to
identify atypical scrapie or BSE in sheep? Thanks. I look forward to hearing
from you.



Warmest Regards,

Jackie Ostfeld



Jacqueline Ostfeld, MA

Food and Drug Safety Associate

Government Accountability Project

1612 K St. NW, Suite 1100

Washington, DC 20006

Phone: (202) 408-0034 Ext. 153

Fax: (202) 408-9855

jacquelineo@whistleblower.org

www.whistleblower.org





NOTICE: This communication may contain privileged or other confidential
information. If you are not the intended recipient, or believe that you have
received this communication in error, please do not print, copy, retransmit,
disseminate, or otherwise use the information. Also, please indicate to the
sender that you have received this communication in error, and delete the
copy you received.



----- Original Message -----
From: Jacqueline Ostfeld
To: Terry S. Singeltary Sr.
Sent: Monday, October 22, 2007 9:20 AM
Subject: RE: Atypical Scrapie


Thanks, Terry.



Jackie



---

Jacqueline Ostfeld

Food and Drug Safety Officer

Government Accountability Project

1612 K St. NW, Suite 1100

Washington, DC 20006

Phone: (202) 408-0034, ext. 153

Fax: (202) 408-9855

jacquelineo@whistleblower.org

www.whistleblower.org



NOTICE: This communication may contain privileged or other confidential information. If you are not the intended recipient, or believe that you have received this communication in error, please do not print, copy, retransmit, disseminate, or otherwise use the information. Also, please indicate to the sender that you have received this communication in error, and delete the copy you received.


--------------------------------------------------------------------------------

From: Terry S. Singeltary Sr. [mailto:flounder9@verizon.net]
Sent: Sunday, October 21, 2007 3:53 PM
To: Jacqueline Ostfeld
Subject: Re: Atypical Scrapie



Tuesday, October 9, 2007

NOR-98 SCRAPIE UPDATE AUGUST 31, 2007 RISES TO 5 DOCUMENTED CASES


http://nor-98.blogspot.com/


***PLEASE NOTE IN USA CJD UPDATE AS AT JUNE 2007, please note steady
increase in ''TYPE UNKNOWN''. ...TSS


1 Acquired in the United Kingdom; 2 Acquired in Saudi Arabia; 3 Includes 17
inconclusive and 9 pending (1 from 2006, 8 from 2007); 4 Includes 17
non-vCJD type unknown
(2 from 1996, 2 from 1997, 1 from 2001, 1 from 2003, 4 from 2004, 3 from
2005, 4 from 2006)
and 36 type pending (2 from 2005, 8 from 2006, 26 from 2007)



http://www.cjdsurveillance.com/pdf/case-table.pdf




USA NVCJD BLOOD RECALLS ONLY ;


http://www.google.com/search?hl=en&q=CJD+BLOOD+RECALLS+TSS&btnG=Search


vCJD case study highlights blood transfusion risk


http://vcjdblood.blogspot.com/


CREUTZFELDT JAKOB DISEASE MAD COW BASE, CWD, SCRAPIE UPDATE OCT 2007


http://cjdmadcowbaseoct2007.blogspot.com/


NOR-98 ATYPICAL SCRAPIE USA UPDATE AS AT OCT 2007

Tuesday, October 9, 2007
NOR-98 SCRAPIE UPDATE AUGUST 31, 2007 RISES TO 5 DOCUMENTED CASES


http://nor-98.blogspot.com/



CREUTZFELDT JAKOB DISEASE MAD COW h-BASE UPDATE USA

http://cjdmadcowbaseoct2007.blogspot.com/



ABSTRACTS SPORADIC CJD AND H BASE MAD COW ALABAMA AND TEXAS SEPTEMBER 2007

Date: Mon, 24 Sep 2007 21:31:55 -0500



I suggest that you all read the data out about h-BASE and sporadic CJD, GSS,
blood, and some of the other abstracts from the PRION2007. ...



http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0709&L=sanet-mg&T=0&F=&S=&P=19744





*** PLEASE READ AND UNDERSTAND THE RAMIFICATIONS OF THIS !!! THE PRICE OF
POKER INDEED GOES UP. ...TSS

USA BASE CASE, (ATYPICAL BSE), AND OR TSE (whatever they are calling it
today), please note that both the ALABAMA COW, AND THE TEXAS COW, both were
''H-TYPE'', personal communication Detwiler et al Wednesday, August 22, 2007
11:52 PM. ...TSS



http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=19779



From: "Terry S. Singeltary Sr."
Subject: CWD UPDATE 88 AUGUST 31, 2007


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0709&L=sanet-mg&T=0&P=450


Date: Wed, 29 Aug 2007 21:13:08 -0500
From: "Terry S. Singeltary Sr."
Subject: CWD NEW MEXICO RECORDS IT'S 19 CASE (near Texas border again)


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=26079



Monitoring the Potential Transmission of Chronic Wasting Disease to Humans
Using a Hunter Registry Database in Wyoming (405 lines)
From: Terry S. Singeltary Sr. <[log in to unmask]>
Date: Thu, 30 Aug 2007 21:23:42 -0500


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&F=&S=&P=27654


Subject: Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease
creates a new prion strain

Date: August 25, 2007 at 12:42 pm PST


Subject: Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease
creates a new prion strain
Date: August 25, 2007 at 12:42 pm PST

J Biol Chem. 2007 Aug 20; : 17709374

Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a
new prion strain.

[My paper] Atsushi Kobayashi , Masahiro Asano , Shirou Mohri , Tetsuyuki
Kitamoto

The genotype (methionine or valine) at polymorphic codon 129 of the human
prion protein (PrP) gene and the type (type 1 or type 2) of abnormal isoform
of PrP (PrP(Sc)) are major determinants of the clinicopathological
phenotypes of sporadic Creutzfeldt-Jakob disease (sCJD). Here we found that
transmission of sCJD prions from a patient with valine homozygosity (129V/V)
and type 2 PrP(Sc) (sCJD-VV2 prions) to mice expressing human PrP with
methionine homozygosity (129M/M) generated unusual PrP(Sc) intermediate in
size between type 1 and type 2. The intermediate type PrP(Sc) was seen in
all examined dura mater graft-associated CJD cases with 129M/M and
plaque-type PrP deposits (p-dCJD). p-dCJD prions and sCJD-VV2 prions
exhibited similar transmissibility and neuropathology, and the identical
type of PrP(Sc) when inoculated into PrP-humanized mice with 129M/M or
129V/V. These findings suggest that p-dCJD could be caused by cross-sequence
transmission of sCJD-VV2 prions.


snip...


In this study, the strain-dependent traits of sCJDMM1
prions were inherited through cross-sequence
transmission without any modification. The
humanized mice with 129V/V produced type 1 PrPres
after inoculation with sCJD-MM1 prions. Because
sCJD-VV1 cases are extremely rare (at most 1-2%
of the total number of sCJD cases) and characterized
by early onset (mean age at onset: 39.3 years) (5),

####################################

our results raise the possibility that CJD cases
classified as VV1 may include cases caused by
iatrogenic transmission of sCJD-MM1 prions or
food-borne infection by type 1 prions from animals,
e.g., chronic wasting disease prions in cervid. In fact,
two CJD-VV1 patients who hunted deer or
consumed venison have been reported (40, 41). The
results of the present study emphasize the need for
traceback studies and careful re-examination of the
biochemical properties of sCJD-VV1 prions.

###################################

In conclusion, cross-sequence transmission of
sCJD-VV2 prions generates a new prion strain with
altered conformational properties and disease
phenotypes as p-dCJD prions. Furthermore, the
newly generated prions have unique transmissibility
including the traceback phenomenon. In the future, if
atypical prion strains emerge through cross-sequence
transmission, especially from animals, traceback
studies will enable us to identify the origin of the
prions.

REFERENCES...snip...end

FULL TEXT ;


http://www.jbc.org/cgi/content/abstract/M704597200v1?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=Cross-sequence+transmission+of+sporadic+Creutzfeldt-Jakob+disease+creates+a+new+&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT



http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=21267



Re: Colorado Surveillance Program for Chronic Wasting Disease
Transmission to Humans (TWO SUSPECT CASES)


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0704&L=sanet-mg&T=0&P=1165




Subject: MAD COW BASE H-TYPE AND L-TYPE

Date: August 23, 2007 at 11:30 am PST


http://lists.ifas.ufl.edu/cgi-bin/wa.exe?A2=ind0708&L=sanet-mg&T=0&P=19779



Quantifying the Species Barrier in Chronic Wasting Disease by a Novel in
vitro Conversion Assay


Li, L1; Coulthart, MB2; Balachandran, A3; Chakrabartty, A4; Cashman, NR1
1University of British Columbia, Brain Research Centre, Canada; 2Public
Health Agency of Canada, National Microbiology Laboratory, Canada; 3Animal
Diseases
Research Institute, Canada Food Inspection Agency, National Reference
Laboratory for Scrapie and CWD, Canada; 4Ontario Cancer Institute and
Department of Medical
Biophysics, University of Toronto, Canada


Background: Chronic wasting disease (CWD) is a transmissible spongiform
encephalopathy that can affect North American cervids (deer, elk, and
moose). Although the risk of CWD crossing the species barrier and causing
human
disease is still unknown, however, definite bovine spongiform encephalopathy
(BSE)
transmission to humans as variant CJD (vCJD), it would seem prudent to limit
the exposure of humans to CWD.


Aim: In view of the fact that BSE can be readily transmitted to non-bovid
species, it is important to establish the species susceptibility range of
CWD.


Methods: In vitro conversion system was performed by incubation of prions
with normal brain homogenates as described before, and protease K (PK)
resistant
PrP was determined by immunoblotting with 6H4 monoclonal prion antibody.


Results: Our results demonstrate that PrPC from cervids (including moose)
can be efficiently converted to a protease-resistant form by incubation with
elk
CWD prions, presumably due to sequence and structural similarities between
these species. Interestingly, hamster shows a high conversion ratio by
PrPCWD.
Moreover, partial denaturation of substrate PrPC can apparently overcome the
structural barriers between more distant species.


Conclusions: Our work correctly predicted the transmission of CWD to a wild
moose. We find a species barrier for prion protein conversion between
cervids and
other species, however, this barrier might be overcome if the PrPC substrate
has been partially denatured in a cellular environment. Such an environment
might also promote CWD transmission to non-cervid species, *** including
humans.
Acid/GdnHCl-treated brain PrPC was a superior substrate for the in vitro
conversion than PrPC treated at physiological pH. This has implications for
the process by which the prion protein is converted in disease.


http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf




P04.61


Survival of PrPSc during Simulated Wastewater Treatment


ProcessesPedersen, J1; Hinckley, G1; McMahon, K2; McKenzie, D3; Aiken,
JM31University of Wisconsin, Soil Science/Civil and Environmental
Engineering,USA; 2University of Wisconsin, Civil and Environmental
Engineering, USA;3University of Wisconsin, Comparative Biosciences,


USA Concern has been expressed that prions could enter wastewater treatment
systems through sewer and/or septic systems (e.g., necropsy laboratories,
rural meat processors, private game dressing) or through leachate from
landfills that have received TSE-contaminated material. Prions are highly
resistant to degradation and many disinfection procedures raising concern
that they could survive conventional wastewater treatment. Here, we report
the results of experiments examiningthe partitioning and survival of PrPSc
during simulated wastewater treatment processes including activated and
mesophilic anaerobic sludge digestion. We establish that PrPSc can be
efficiently extracted from activated and anaerobic digester sludges with
1% sodium dodecyl sulfate, 10% sodium undecyl sulfate, and 1% sodium
N-laurylsarcosinate. Activated sludge digestion does not result in
significant degradation ofPrPSc. The protein partitions strongly to the
activated sludge solids and isexpected to enter biosolids treatment
processes. A large fraction of PrPSc survivedsimulated mesophilic anaerobic
sludge digestion. Our results suggest that if prions were to enter municipal
waste water treatment systems, most of the agent would partition to
activated sludge solids, survive mesophilic anaerobic digestion, and be
present in treated biosolids. Land application of biosolids
containing prions could represent a route for their unintentional
introduction into the environment.Our results argue for excluding inputs of
prions to municipal wastewater treatment facilities that would result in
unacceptable risk of prion disease transmission via contaminated
biosolids.

http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf


P04.01ChronicWasting Disease in a Captive White-Tailed Deer Farm


Keane, D1; Barr, D1;
Bochsler, P1; Hall, M2; Gidlewski, T3; O'Rourke, K4; Spraker, T51University
of Wisconsin, USA; 2US Department of Agriculture, USA; 3US Departmentof
Agriculture, USA; 4USDA ARS-ADRU, Washington |State University,
USA;5Veterinary Diagnostic Laboratory, Colorado State University, USA


A white-tailed deer farm in Portage, Wisconsin, was depopulated in January
2006, after chronic wasting disease (CWD) had been initially discovered on
the property in September 2002. Prior to the depopulation, a total of 22
positive animals had been removed from the property: one in 2002, six in
2003, ten in 2004, four in 2005 and one in 2006. At the time of depopulation
a total of 76 animals remained: 47 females and 29males. Age was assessed by
visual examination of teeth at the time of death and revealed 26 adult, 8
fawn and 42 yearling animals. The following tissues were examined by
immunohistochemistry for PrPCWD using A b99/97.6.1: obex,
tonsil, retropharyngeal, submandibular, parotid, prescapular, axillary,
inguinal, prefemoral andpopliteal lymph nodes, recto-anal mucosal tissue
and eye. Seventy-nine percent ofanimals (sixty) were found to be positive
in at least one tissue; 49 were obex positive, 58 retropharyngeal positive,
56 tonsil positive, 48 recto-anal mucosal associated lymphoid tissue
positive and 4 animals were positive for PrPCWD in the retina.
Priongenotype was determined for all animals.


http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf


Subject: Clinical Observations of BSE Infection in Red Deer
Date: October 4, 2007 at 9:05 am PST

P04.80

Clinical Observations of BSE Infection in Red Deer

Steele, P1; Martin, S2; Jeffrey, M2; González, L2; Sisó, S2; Finlayson, J1;
Hamilton, S1; Eaton, Samatha L1; Reid, Hugh W1; Todd, R1; Pang, Y1;
Chianini, F1;
Dagleish, MP1 1Moredun Research Institute, UK; 2Veterinary Laboratory
Agency, Lasswade, UK


Observation of clinical signs is often the first step in the diagnosis of
TSE diseases in
experimental, farmed and wild animals. Clinical presentation of chronic
wasting
disease (CWD) infected deer varies widely as disease progresses and many
clinical signs observed can be non-specific to TSE infection, however by
terminal
stage the majority of cases involve behavioural changes and loss of body
condition.
We present here the first description of clinical disease in deer
experimentally infected
with BSE. These data are part of the results of an ongoing project to
investigate the
susceptibility of UK red deer (Cervus elaphus elaphus) to BSE infection
either by
alimentary or intra-cerebral infection.
Eighteen European red deer calves (mean 64 days old) were challenged
intragastrically with 25g of BSE-infected bovine brain. Six challenged and 2
control deer
were culled at 6 and 12 month post infection. These animals showed no
clinical signs
and no disease-specific PrP (PrPd) on immunohistochemistry (IHC) examination
of a wide range of tissues collected at post-mortem. Six BSE-dosed and 4
negative
control deer are still alive at time of writing (1384 dpi).
Subsequently, 6 red deer of the same cohort (mean 341 days old) were
challenged with
0.05g of BSE positive bovine brain material and 2 with sterile saline by the
intracerebral route. Currently (1106 dpi), five of the six challenged
animals have
developed clinical signs and terminal disease confirmed by IHC and western
blot
detection of PrPd.
Clinical signs similar to CWD cases have been observed including behavioral
change, wide stance, lowered head, and excessive salivation. All animals had
significant weight loss attributed to inability or unwillingness to feed,
with inhalation
pneumonia occurring in the case of one animal which is commonly observed in
CWD
cases. The first animal to show clinical signs was markedly different to the
four subsequent
cases. This animal had to be culled following several behavioral episodes
causing
physical injury. Our results prove for the first time that UK red deer are
susceptible to
intra-cerebral BSE infection and shows that the clinical presentation of
disease shares
many similarities to that recorded for CWD.


http://www.prion2007.com/pdf/Prion%20Book%20of%20Abstracts.pdf





Terry S. Singeltary Sr.
P.O. Box 42
Bacliff, Texas USA 77518







----- Original Message -----

From: Jacqueline Ostfeld

To: Terry S. Singeltary Sr.

Sent: Monday, December 04, 2006 1:31 PM

Subject: Atypical Scrapie



Dear Terry,



I spoke with you a month or so ago regarding GAP’s research into scrapie. I am still doing research on scrapie in the US sheep population and I have a question that you may be able to answer or perhaps point me in the right direction. I am wondering if the US has ever found any cases of atypical scrapie beyond those of the mad sheep in Vermont (which is debatable). Do you know if the USDA has any procedures or pilot tests in place to try to identify atypical scrapie or BSE in sheep? Thanks. I look forward to hearing from you.



Warmest Regards,

Jackie Ostfeld



Jacqueline Ostfeld, MA

Food and Drug Safety Associate

Government Accountability Project

1612 K St. NW, Suite 1100

Washington, DC 20006

Phone: (202) 408-0034 Ext. 153

Fax: (202) 408-9855

jacquelineo@whistleblower.org

www.whistleblower.org





NOTICE: This communication may contain privileged or other confidential information. If you are not the intended recipient, or believe that you have received this communication in error, please do not print, copy, retransmit, disseminate, or otherwise use the information. Also, please indicate to the sender that you have received this communication in error, and delete the copy you received.